Project Grant R34DA061732
Award Date
9/15/24
Completion Date
8/31/27
Dollars Obligated
$252K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $707,647 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Weill Medical College of Cornell University to conduct research on universal hepatitis C virus (HCV) screening during pregnancy. The project aims to: 1) determine if revised HCV testing guidelines led to increased testing rates among pregnant women compared to non-pregnant women; 2) assess if the guidelines increased postpartum HCV linkage to care, treatment,...
This federal Project Grant award of $2,332,500 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The objective of this 4-year project is to build a "prison learning health system" to improve the quality, efficiency, and reach of HIV, HIV risk, and substance use disorder (SUD) care in Washington state prisons. Key innovations include: 1) establishing quality metrics and a patient advisory board to guide...
This federal Project Grant award, with ID R01DA059503, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,192,612 grant will fund a 5-year research project by The Miriam Hospital, a non-profit healthcare and research institution in Providence, RI, to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives of this multidisciplinary research...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $3,086,472 to the University of Rhode Island on September 15, 2024. The objective of this 5-year project is to evaluate the spillover effects of HIV interventions among marginalized populations, particularly young Black men who have sex with men (BMSM), who use illicit substances. The project will leverage data from three existing network studies in Chicago,...
The federal Project Grant award, identified as R61DA062365, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,551,042 award will establish a Regional Research Hub (RRH) in the greater Metropolitan Atlanta area to improve linkages to care for a recently incarcerated, HIV status-neutral group of individuals experiencing substance use disorder (SUD). The project aims to: (1) pilot test a previously developed...
This $1,210,300 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of novel polyvalent HIV vaccines designed to prevent intravenous transmission in people who inject drugs (PWID). The research team at Beth Israel Deaconess Medical Center, Inc. (BIDMC) will create diverse HIV envelope-based vaccines and evaluate their ability to rapidly clear multiple viral strains in animal models, with...
This federal Project Grant award of $435,313 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop a cost-based epidemiological planning tool to guide public health response to the combined HIV, hepatitis C (HCV), and opioid use disorder (OUD) epidemics. Specifically, the project will: 1) Create an interactive, web-based dashboard to assist policymakers in planning an effective response and provide improved estimates...
This federal Project Grant award of $157,684, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to understand inequities in harm reduction services (HRS) provided to persons with opioid use disorder in hospital settings. The study will use natural language processing (NLP) and electronic health record (EHR) data to characterize providers' recommendations of psychosocial/environmental and...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $884,453 Project Grant to Brigham & Women's Hospital Inc. to develop a rapid, cost-effective point-of-care (POC) diagnostic test for Hepatitis C Virus (HCV) detection. The 5-year project, which commenced on November 22, 2024, aims to create a highly sensitive and specific HCV antigen (Ag) testing solution that can streamline...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $460,432 Project Grant to the Regents of the University of Minnesota to develop and pilot a comprehensive telehealth program at syringe service programs (SSPs) to engage people who inject drugs (PWID) into the HIV care continuum. The key products and services to be delivered include: Conducting formative research to understand determinants of HIV and addiction among...